(2023)
Malignancy Risk of Follicular Neoplasm (Bethesda IV) With Variable Cutoffs of Tumor Size: A Systemic Review and Meta-Analysis.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM.
00,
00
(2023)
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
PLOS ONE.
18,
11
(2023)
Mortality rate and causes of death in papillary thyroid microcarcinoma.
ENDOCRINE.
-,
-
(2023)
Preoperative identification of low‑risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
SCIENTIFIC REPORTS.
13,
1
(2023)
Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case–control study.
SCIENTIFIC REPORTS.
13,
1
(2023)
Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status.
ANNALS OF SURGICAL ONCOLOGY.
-,
-
(2023)
Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea.
THYROID.
33,
1
(2022)
Identification of Mutations in the Thyroxine-Binding Globulin (TBG) Gene in Patients with TBG Deficiency in Korea.
ENDOCRINOLOGY AND METABOLISM.
37,
6
(2022)
The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy.
EPILEPSIA.
63,
12
(2022)
Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study.
FRONTIERS IN ENDOCRINOLOGY.
13,
-
(2022)
Ultrasonographic characteristics of H?rthle cell neoplasms: prediction of malignancy.
ULTRASONOGRAPHY.
41,
4
(2022)
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients.
ENDOCRINOLOGY AND METABOLISM.
37,
4
(2022)
Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy.
Clinical Endocrinology.
97,
1
(2022)
Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women.
ENDOCRINOLOGY AND METABOLISM.
37,
3
(2022)
Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study.
ENDOCRINOLOGY AND METABOLISM.
37,
2
(2022)
Effect of TSH levels during active surveillance of PTMC according to age.
ENDOCRINE-RELATED CANCER.
29,
4
(2021)
Surgeon Volume and Long-Term Oncologic Outcomes in Patients with Medullary Thyroid Carcinoma.
ANNALS OF SURGICAL ONCOLOGY.
28,
13
(2021)
Metastatic lymph node ratio for predicting recurrence in medullary thyroid cancer.
CANCERS.
13,
22
(2021)
Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
SCIENTIFIC REPORTS.
11,
1
(2021)
Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma.
FRONTIERS IN ENDOCRINOLOGY.
12,
-
단행본
(2016)
임상 내분비학 3판.
도서출판 고려의학.
공동
(2011)
내분비대사학.
군자출판사.
공동
(2010)
HARRISON'S 내과학.
도서출판 MIP.
공동
특허/프로그램
AHR 분류에 기반한 갑상선암 옣 예측 방법 및 시스템.
10-2017-0097579.
20200219.
대한민국
학술회의논문
(2023)
Clinical manifestations of malignant stma ovarii in a tertiary hospital in Korea.
2023년 대한갑상선학회 추계학술대회.
대한민국
(2023)
The association between BMI and BRAFV600E mutation status may differ by primary tumor size.
2023년 대한갑상선학회 추계학술대회.
대한민국
(2023)
Initial clinical outcmes of papillary thyroid cancer with with TERT promoter mutation from real world data.
2023 대한갑상선학회 추계학술대회.
대한민국
(2023)
Can TERT promoter mutation be a poor prognostic factor in undifferentiated thyroid carcinoma?.
2023년 대한갑상선학회 춘계학술대회 및 연수강좌.
대한민국
(2023)
Association between BMI and BRAF mutational status may differ by primary tumor size.
ENDOCRINOLOGY AND METBOLISM.
대한민국
(2021)
Laboratory test & molecular biomarker in assessment of thyroid nodules.
2021 대한갑상선내분비외과학회 School of Endocrine Surgeons.
대한민국
(2020)
Total Thyroidectomy in Operable Medullary Thyroid Cancer.
AOCE-SICEM 2020.
대한민국
(2020)
Adequate levothyroxine dose for TSH suppression in differentiated thyroid cancer patients after total thyroidectomy.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
Bone meneral density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients with TSH suppression therapy.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
Changes in the levels of thyrotropin binding inhibitory immunoglobulins following total thyroidectomy or radioiodine therapy in patients with refractory Graves' disease.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
Preoperative serum thyroglobulin and its correlation with the burden and extent of differentiated thyroid cancer.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
The incidence of childhood thyroid cancer continues to increase despite a decline in adult thyroid cancer in Korea.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2019)
Cancer Panel in Seoul Samsung Hospital.
2019 대한갑상선학회 추계학술대회.
대한민국
(2019)
갑상선기능저하증의 치료와 경과관찰.
대한내과학회 제2차 내과분과전문의 연수교육.
대한민국
(2019)
갑상선 기능항진증의 적절한 치료.
2019 대한갑상선학회 춘계학술대회 및 연수강좌.
대한민국
(2018)
Immune Mediated Endocrinopathy.
2018 KALC International Conference.
대한민국
(2018)
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma : A multi-institutinal cohort study.
EnM Endocrinology and Metabolism Endocrine Week 2018.
대한민국
(2018)
Treatment of Graves' Disease : Long-term Medical Therapy or Radioactive Iodine Therapy.
EnM Endocrinology and Metabolism The 6th Seoul International Congress of Endocrinology and Metabolism (SICEM 2018).
대한민국
(2018)
Expression of cyclin D1/p27 protein predicts structure recurrence of papillary thyroid cancer according to nodal stage.
대한갑상선학회 창립 10주년 기념 2018 춘계학술대회 및 연수강좌.
대한민국
